RecruitingNCT05837936

Total Intravenous Anesthesia (TIVA)/Sevoflurane Initiated Intravenous Anesthesia (SIIVA) in Pediatric Patients

A Prospective Observational Study Evaluating Extubation Criteria in Children Less 10 Years of Age and Younger Undergoing Intravenous Anesthesia


Sponsor

Wake Forest University Health Sciences

Enrollment

600 participants

Start Date

Mar 28, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Because Propofol is the primary "anesthetic agent," and inhalational agents remain in trace quantities at the end of the procedure Sevoflurane initiated intravenous anesthesia (SIIVA) or not present at all Total intravenous anesthesia (TIVA) it is likely that different criteria may be predictive of extubation success in these patients compared to inhalational anesthesia.


Eligibility

Max Age: 9 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Sevoflurane initiated intravenous anesthesia (SIIVA) and Total intravenous anesthesia (TIVA) for people with extubation. The study is currently recruiting participants at 2 locations. People eligible for this study include up to age 9 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERTotal intravenous anesthesia (TIVA)

TIVA anesthetic -no inhalational gases for surgery

OTHERSevoflurane initiated intravenous anesthesia (SIIVA)

SIIVA - sevoflurane anesthetic gases for surgery


Locations(2)

Atrium Health Wake Forest Baptist

Winston-Salem, North Carolina, United States

Perth Children's Hospital

Perth, Australia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05837936


Related Trials